PSGR/OR51E2 expression levels have been found to correlate with prognosis (Cao et al., 2015), and a mouse model of PSGR/OR51E2 overexpression suggests that this receptor does indeed play a role in tumor development (Rodriguez et al., 2014). Here, OR51E2 is linked to neoplasm.